Equity · United StatesEUR-hedged share classSFDR art. 6
Index tracked: NASDAQ - 100 Notional NTR Index
TER
0.35%+ trans. 0.02%
Fund size
15.1 bn EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 17 Oct 2017 · costs from the KID as of 14 Aug 2026 · 103 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
- The objective of the Fund is to provide investors with investment results which, before expenses, correspond to the price and yield performance of the return on the NASDAQ-100 Notional Index (Net Total Return) in USD (the "Index") - The Fund’s base currency is USD. - The Index combines 100 of the largest (in terms of market capitalization) domestic and international non-financial companies listed on the NASDAQ Stock Market from the main sectors of activity, mainly concentrated in technology, but also in other important sectors such as consumer goods…
Performance since series start (in euro) — base 100
17 Oct 2017 → 14 Aug 2026 · dividends reinvested where declared by the issuer
High 422 (2 Jun 2026) · low 96 (21 Dec 2018) · last 412. Past performance is not indicative of future results.
RebalixEQEU · IE00BYVTMS52 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 103 securities · top-10 weight = 46.5%
The live sheet, always up to date rebalix.com/en/etf/IE00BYVTMS52 Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.